KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results Jul 15, 2019 KalVista Pharmaceuticals Announces Changes to Board of Directors Jul 1, 2019 KalVista Pharmaceuticals Presents KVD900 Data at European Academy of Allergy and Clinical Immunology Jun 4, 2019 All News
KalVista Pharmaceuticals Presents KVD900 Data at European Academy of Allergy and Clinical Immunology Jun 4, 2019
